2nd Quarter - Report

CROSSROADS STRATEGIES, LLC for EISAI, INC.

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Implementation issues related to the Pharmaceutical Quality, Security, and Accountability Act (P.L. 113-54). Regulatory and legislative health care issues. 340B issues.

LobbyistCovered position, as disclosed
ANNE BRADY —
JOHN GREEN —
STEWART HALL —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JAKE PERRY —
STEVE TILTON —
TODD MATTHEW WEISS —
MATT WISE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

H.R.2404/S.1509, Treat and Reduce Obesity Act of 2015; Part D issues.

LobbyistCovered position, as disclosed
ANNE BRADY —
JOHN GREEN —
STEWART HALL —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JAKE PERRY —
STEVE TILTON —
TODD MATTHEW WEISS —
MATT WISE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1509 (114th), H.R. 2404 (114th)

Budget/Appropriations BUD

S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; Drug Enforcement Administration (DEA) issues; H.CON.RES.27/S.CON.RES.11, Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025.

LobbyistCovered position, as disclosed
ANNE BRADY —
JOHN GREEN —
STEWART HALL —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JAKE PERRY —
STEVE TILTON —
TODD MATTHEW WEISS —
MATT WISE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.Con.Res. 27 (114th), S.Con.Res. 11 (114th), S. 1695 (114th), H.R. 3020 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.